Levetiracetam for seizures

A treatment and a condition, followed through the public trial records. Not medical advice. How a status is set

Phase 2 trial. Mid-stage trial in people. As of 19 Nov 2026, from 1 registered trial.

Why this status

  1. 19 Aug 2025: Trial registered, NCT07130786
  2. 23 Dec 2025: Trial started, NCT07130786

The trials

NCT07130786: Prophylactic Anti-Seizure Medication vs No Anti-Seizure Medication for Patients With Primary Motor Cortex Brain Metastases

State
Under way
Phase
Phase 2
People
150 planned
Started
23 Dec 2025
Primary completion
Feb 2029
Arms
Prophylactic Levetiracetam
Results
None posted
  1. 19 Aug 2025: Trial registered
  2. 23 Dec 2025: Trial started

How the status changed

  1. 19 Nov 2026: First set: Phase 2 trial

About the treatment

Also known as Elepsia, Levetiracetam accord, Levetiracetam actavis, Levetiracetam actavis group, Levetiracetam hospira, Levetiracetam ratiopharm, Levetiracetam sun, Levetiracetam teva, Matever.

Registries searched: ClinicalTrials.gov, through 17 Nov 2026.